These results suggest that the DUB3–cyclin A axis plays a key role in G1/S transition during cell cycle progression and at least partially explain the mechanism of DUB3 which promotes the proliferation of NSCLC cells, providing a promising target for NSCLC treatment [85]. The gene discussed is USP17L2; the disease is non-small cell lung carcinoma.